glp-1 agonist depression An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders Now, new research suggests that

Introduced in the twenty-first century, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of antidiabetic drugs noted not only for their potent glucose-lowering effects but also for their cardiovascular and renal protective benefits

Brand: Pendulum

are the major companies operating in this market.

Commonly prescribed GLP-1RAs: Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Study overview: What was investigated

But without scientific data, the risks may outweigh the benefits.

Over the past year, more patients have come to us asking about Ozempic (semaglutide) and similar GLP-1 receptor agonists for their role in weight loss but also for effects on []